Literature DB >> 30121298

Two siblings with PRKDC defect who presented with cutaneous granulomas and review of the literature.

Saliha Esenboga1, Can Akal2, Betül Karaatmaca3, Baran Erman4, Sibel Dogan5, Diclehan Orhan6, Kaan Boztug7, Deniz Ayvaz3, İlhan Tezcan3.   

Abstract

V(D)J recombination, during which recognition and repair of broken DNA chains are accomplished by non-homologous end joining pathway, is a critical process in B and T cell development.Null mutations of each enzyme or protein of this pathway result in T- B- NK+ severe combined immunodeficiency whereas hypomorphic mutations result in atypical(leaky)severe combined immunodeficiency forms. We present two siblings with PRKDC (Protein Kinase, DNA-Activated, Catalytic Polypeptide) mutation who presented with granulomatous skin lesions and recurrent lung infections. Primary immune deficiencies may initially present with skin findings. Disruption in central and peripheral B-cell tolerance and impaired intrathymic T-cell maturation,a central player in T-cell tolerance, have been identified as the mechanism of autoimmunity and granuloma seen in patients. The variation in clinical phenotypes of patients with PRKDC mutation suggests that additional factors such as modifying genes, epigenetic and environmental factors may affect the severity and clinical phenotype of the disease. Functional studies during the follow-up and evaluation before and after hematopoeitic stem cell transplantation will hopefully increase our knowledge about the autoimmune and inflammatory process of the disease spectrum.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30121298     DOI: 10.1016/j.clim.2018.08.002

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  7 in total

Review 1.  DNA-Dependent Protein Kinase Catalytic Subunit: The Sensor for DNA Double-Strand Breaks Structurally and Functionally Related to Ataxia Telangiectasia Mutated.

Authors:  Yoshihisa Matsumoto; Anie Day D C Asa; Chaity Modak; Mikio Shimada
Journal:  Genes (Basel)       Date:  2021-07-27       Impact factor: 4.096

Review 2.  Update on DNA-Double Strand Break Repair Defects in Combined Primary Immunodeficiency.

Authors:  Mary A Slatter; Andrew R Gennery
Journal:  Curr Allergy Asthma Rep       Date:  2020-07-09       Impact factor: 4.806

3.  DNA-PK deficiency potentiates cGAS-mediated antiviral innate immunity.

Authors:  Xiaona Sun; Ting Liu; Jun Zhao; Hansong Xia; Jun Xie; Yu Guo; Li Zhong; Mi Li; Qing Yang; Cheng Peng; Isabelle Rouvet; Alexandre Belot; Hong-Bing Shu; Pinghui Feng; Junjie Zhang
Journal:  Nat Commun       Date:  2020-12-03       Impact factor: 14.919

4.  Biomarkers of DNA Damage Response Enable Flow Cytometry-Based Diagnostic to Identify Inborn DNA Repair Defects in Primary Immunodeficiencies.

Authors:  Kerstin Felgentreff; Ulrich Baumann; Christian Klemann; Catharina Schuetz; Dorothee Viemann; Martin Wetzke; Ulrich Pannicke; Sandra von Hardenberg; Bernd Auber; Klaus-Michael Debatin; Eva-Maria Jacobsen; Manfred Hoenig; Ansgar Schulz; Klaus Schwarz
Journal:  J Clin Immunol       Date:  2021-10-30       Impact factor: 8.317

5.  Physical ARTEMIS:DNA-PKcs interaction is necessary for V(D)J recombination.

Authors:  Doris Niewolik; Klaus Schwarz
Journal:  Nucleic Acids Res       Date:  2022-02-28       Impact factor: 16.971

6.  Potential value of PRKDC as a therapeutic target and prognostic biomarker in pan-cancer.

Authors:  Xiawei Yang; Feng Yang; Liugen Lan; Ning Wen; Haibin Li; Xuyong Sun
Journal:  Medicine (Baltimore)       Date:  2022-07-08       Impact factor: 1.817

7.  Uncovering DNA-PKcs ancient phylogeny, unique sequence motifs and insights for human disease.

Authors:  James P Lees-Miller; Alexander Cobban; Panagiotis Katsonis; Albino Bacolla; Susan E Tsutakawa; Michal Hammel; Katheryn Meek; Dave W Anderson; Olivier Lichtarge; John A Tainer; Susan P Lees-Miller
Journal:  Prog Biophys Mol Biol       Date:  2020-10-06       Impact factor: 4.799

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.